Understanding the Science

What Is Circulating Tumour DNA (ctDNA)?

DNA contains genetic information used by cells to function and grow. When cells break down, they can release small DNA fragments into the bloodstream. These fragments are known as cell-free DNA, or cfDNA. When such fragments originate from tumour cells, they are referred to as circulating tumour DNA (ctDNA).

A ctDNA test uses laboratory techniques to analyse these fragments for particular genetic changes, patterns or signals. The exact approach depends on the test being used. Some ctDNA tests support cancer treatment decisions or monitoring, while other blood-based tests are designed to look for signals associated with multiple cancers.

This is why it is important to understand what a specific early cancer detection blood test is designed to detect, which cancers are covered by its panel, and what follow-up procedures may be required.

How Testing Works

How Does a ctDNA Blood Test Work?

The process varies by laboratory and test type. In general, a ctDNA blood test involves collecting a blood sample, analysing the sample in a laboratory, and interpreting the findings against the test's validated criteria.

Can a blood test detect cancer before symptoms appear?

Some multi-cancer early detection tests are designed to identify cancer-associated signals that may be present before symptoms develop. However, early detection is not guaranteed. Performance varies by cancer type, disease stage, the test used and the population being tested.

If you have unexplained symptoms, do not rely on a screening blood test alone. Arrange a medical assessment even if a previous test result was negative.

Key Differences

ctDNA vs cfDNA: What Is the Difference?

The terms ctDNA and cfDNA are related, but they do not mean the same thing. Understanding the difference can help when researching a ctDNA test in Malaysia or reading about liquid biopsy technology.

Not every liquid biopsy is designed for early cancer screening. Some tests are intended for people who have already been diagnosed with cancer, while others are designed to look for signals associated with cancer in a screening setting. Always check the intended use of the specific test.

Multi-Cancer Screening

What Is a Multi-Cancer Early Detection Test?

A multi-cancer early detection test, sometimes abbreviated as MCED, is designed to look for signals associated with more than one cancer type through a single testing approach. Some tests use blood-based analysis, including methods involving circulating tumour DNA or other cancer-associated signals.

The specific cancers included, the laboratory methods used and the reported findings depend on the individual test. A multi-cancer blood test should not be assumed to screen for every type of cancer.

How is a multi-cancer blood test different from routine screening?

Established screening programmes target specific cancers in eligible populations and may involve procedures such as mammography, cervical screening or colorectal cancer screening. A multi-cancer early detection test is a different approach and should not automatically replace those established methods.

Ask a healthcare professional how a proposed test fits your age, personal medical history, family history and existing screening plan.

Benefits and Limitations

Potential Benefits and Limitations of ctDNA Testing

Interest in blood-based cancer detection has grown because a blood sample can be analysed for cancer-associated signals without initially requiring a tissue biopsy. However, the value of a test depends on its intended use, clinical evidence and individual circumstances.

Can ctDNA testing produce false-positive or false-negative results?

Yes. As with other screening approaches, a result may not perfectly reflect whether cancer is present. A false-positive result can lead to additional investigations when cancer is not ultimately found. A false-negative result can occur when the test does not identify a cancer-associated signal that is present.

Ask the provider about the test's performance data, intended population, possible follow-up procedures and how the result should be interpreted.

Suitability

Who May Consider an Early Cancer Detection Blood Test?

Whether an additional cancer screening test is appropriate depends on several factors. A consultation can help you understand potential benefits, limitations and alternative screening options.

• Adults exploring additional screening: People who want to learn about additional screening options may discuss their choices with a healthcare professional.
• People with a family history of cancer: A family history may affect which screening or risk-assessment options are appropriate.
• People reviewing their preventive healthcare plan: A clinician can help determine how any additional test fits with recommended screening based on age, sex, medical history and risk.

A ctDNA blood test is not a substitute for investigating symptoms, following up on an abnormal result or attending established cancer screening when recommended. People with a personal history of cancer should discuss the intended use of a test with their treating team.

Your Appointment

What to Expect During a ctDNA Test

The exact procedure depends on the test provider. If you are considering a blood-based early cancer detection test, ask about preparation, sample collection, result timelines and follow-up arrangements before booking.

1. Discuss your health background Share relevant medical and family history, current symptoms, previous results and existing screening arrangements.
2. Confirm the test details Ask which cancers are included in the panel, what the test is designed to detect and what its limitations are.
3. Provide a blood sample A healthcare professional collects the sample according to the provider's procedure. Follow any instructions given before the visit.
4. Receive and review the results Ask how results will be communicated and who can explain the findings.
5. Discuss any next steps Depending on the result and your circumstances, a clinician may recommend further assessment or routine follow-up.

Common Questions

Frequently Asked Questions About ctDNA Testing

These answers explain common questions about ctDNA blood tests, multi-cancer early detection and the SpotMas ctDNA service in Johor Bahru.